We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Did you mean PadmaaVAT
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
AVU provides services for genotypic antiviral resistance testing of HIV and HCV, investigation of HIV transmission events and HSV antiviral resistance testing by phenotyping.
Comply with good pharmacovigilance practice and prepare for an inspection.
Information about the risks of taking valproate medicines during pregnancy.
Pharmacovigilance system requirements
You must tell DVLA if you have pulmonary arterial hypertension and you're receiving treatment from a specialist centre - download the correct form to let them know.
The characteristics, diagnosis, epidemiology of hantaviruses.
Information for patients, public and health care professionals.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
You must tell DVLA if you have heart palpitations - download the correct form to let them know
Information on the diagnosis, prevention and treatment of human parainfluenza viruses (HPIVs).
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
How to apply for an authorisation to manufacture authorised veterinary medicines or medicines marketed under the Exemptions for small pet animals.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Guidance for specialists for initiation of valproate in female patients and for annual review and pregnancy testing to support adherence to pregnancy prevention requirements during the pandemic.
Report certain types of medical conditions to DVLA if you're a lorry, bus or coach driver.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).